WVE - CIK 0001631574
Wave Life Sciences Ltd. has filed 695 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (235 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-05-18 | 2026-05-18 |
| SCHEDULE 13G/A | - | 2026-05-13 | - |
| Proxy statement | DEF 14A | 2026-05-07 | 2026-06-22 |
| SCHEDULE 13G/A | - | 2026-05-06 | - |
| PRER14A | - | 2026-05-01 | - |
| Annual report (amended) | 10-K/A | 2026-04-30 | 2025-12-31 |
| Quarterly report | 10-Q | 2026-04-28 | 2026-03-31 |
| Major company event | 8-K | 2026-04-28 | 2026-04-28 |
| Proxy materials | DEFA14A | 2026-04-21 | - |
| Major company event | 8-K | 2026-04-21 | 2026-04-21 |
| SCHEDULE 13D/A | - | 2026-04-17 | - |
| New insider ownership | 3 | 2026-04-17 | 2026-04-09 |
| New insider ownership | 3 | 2026-04-17 | 2026-04-09 |
| PRE 14A | - | 2026-04-15 | 2026-04-15 |
| Proxy materials | DEFA14A | 2026-04-15 | - |
| Major company event | 8-K | 2026-04-15 | 2026-04-15 |
| SCHEDULE 13D/A | - | 2026-03-30 | - |
| Insider trade | 4 | 2026-03-30 | 2026-03-26 |
| Insider trade | 4 | 2026-03-26 | 2026-03-23 |
| Major company event | 8-K | 2026-03-26 | 2026-03-26 |
| Insider trade | 4 | 2026-02-27 | 2026-02-26 |
| Annual report | 10-K | 2026-02-26 | 2025-12-31 |
| Major company event | 8-K | 2026-02-26 | 2026-02-26 |
| SCHEDULE 13G/A | - | 2026-02-12 | - |
| Insider trade | 4 | 2026-02-11 | 2026-02-05 |
| Insider trade | 4 | 2026-02-11 | 2026-02-05 |
| Insider trade | 4 | 2026-02-11 | 2026-02-05 |
| Insider trade | 4 | 2026-02-11 | 2026-02-05 |
| Insider sale notice | 144 | 2026-02-09 | - |
| Insider sale notice | 144 | 2026-02-09 | - |
| Insider sale notice | 144 | 2026-02-09 | - |
| SCHEDULE 13G | - | 2026-02-05 | - |
| Major company event | 8-K | 2026-02-02 | 2026-02-02 |
| Major company event | 8-K | 2026-01-12 | 2026-01-12 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2025-12-15 | 2025-12-11 |
| SCHEDULE 13D/A | - | 2025-12-15 | - |
| Prospectus supplement | 424B5 | 2025-12-11 | - |
| Major company event | 8-K | 2025-12-11 | 2025-12-09 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider sale notice | 144 | 2025-12-09 | - |
| Insider sale notice | 144 | 2025-12-08 | - |
| Insider sale notice | 144 | 2025-12-08 | - |